Funding for this research was provided by:
Ovarian Cancer Research Fund (155825/155823)
Text and Data Mining valid from 2018-07-06
Received: 1 February 2018
Accepted: 25 June 2018
First Online: 6 July 2018
Ethics approval and consent to participate
: All animals were obtained from the Stem Cell and Xenograft Core (SCXC) of the Abramson Cancer Center, University of Pennsylvania. Mice were bred, treated, and maintained under pathogen-free conditions in-house under the University of Pennsylvania IACUC-approved protocols and as mandated by federal law and regulations. The experimental protocol was conducted in accordance with the recommendations of the Guide for Care and Use of Laboratory Animals with respect to restraint, husbandry, surgical procedures, feed and fluid regulation, and veterinary care. The animal care and use program at the University of Pennsylvania is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).
: Not applicable.
: DJP holds patents in the area of CAR T cell therapy for oncology. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.